Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Genomic investigation of dedifferentiated liposarcoma suggests a role for therapeutic targeting of the tumor epigenome.

Meltzer PS, Helman LJ.

Cancer Discov. 2011 Dec;1(7):555-6. doi: 10.1158/2159-8290.CD-11-0291.

2.

Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas.

Taylor BS, DeCarolis PL, Angeles CV, Brenet F, Schultz N, Antonescu CR, Scandura JM, Sander C, Viale AJ, Socci ND, Singer S.

Cancer Discov. 2011 Dec;1(7):587-97. doi: 10.1158/2159-8290.CD-11-0181.

3.

Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma.

Hisaoka M, Matsuyama A, Nakamoto M.

Am J Pathol. 2012 May;180(5):2076-83. doi: 10.1016/j.ajpath.2012.01.042. Epub 2012 Mar 17.

PMID:
22429966
4.

Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.

Boland JM, Colby TV, Folpe AL.

Am J Surg Pathol. 2012 Sep;36(9):1395-403. doi: 10.1097/PAS.0b013e3182562bc1.

PMID:
22895273
5.

c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.

Snyder EL, Sandstrom DJ, Law K, Fiore C, Sicinska E, Brito J, Bailey D, Fletcher JA, Loda M, Rodig SJ, Dal Cin P, Fletcher CD.

J Pathol. 2009 Jul;218(3):292-300. doi: 10.1002/path.2564.

PMID:
19449367
6.

H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.

Sakamoto A, Oda Y, Adachi T, Tamiya S, Matsuda S, Tanaka K, Iwamoto Y, Tsuneyoshi M.

Am J Clin Pathol. 2001 Feb;115(2):235-42.

PMID:
11211612
7.

Lipomatous tumors.

Weiss SW.

Monogr Pathol. 1996;38:207-39. Review.

PMID:
8744279
8.

Gains of 13q are correlated with a poor prognosis in liposarcoma.

Schmidt H, Bartel F, Kappler M, Würl P, Lange H, Bache M, Holzhausen HJ, Taubert H.

Mod Pathol. 2005 May;18(5):638-44.

9.

Alterations of the RB1 gene in dedifferentiated liposarcoma.

Takahira T, Oda Y, Tamiya S, Yamamoto H, Kobayashi C, Izumi T, Ito K, Iwamoto Y, Tsuneyoshi M.

Mod Pathol. 2005 Nov;18(11):1461-70.

10.

Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: usefulness of cytogenetic and molecular genetic analyses.

Benchetritt M, Hofman V, Vénissac N, Brennetot C, Italiano A, Aurias A, Padovani B, Pedeutour F, Hofman P.

Cancer Genet Cytogenet. 2007 Dec;179(2):150-5.

PMID:
18036404
11.

Cytogenetic and molecular cytogenetic findings in dedifferentiated liposarcoma with neural-like whorling pattern and metaplastic bone formation.

Macarenco RS, Erickson-Johnson M, Wang X, Jenkins RB, Nascimento AG, Oliveira AM.

Cancer Genet Cytogenet. 2007 Jan 15;172(2):147-50.

PMID:
17213023
12.

The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors.

Louis-Brennetot C, Coindre JM, Ferreira C, Pérot G, Terrier P, Aurias A.

Genes Chromosomes Cancer. 2011 Nov;50(11):896-907. doi: 10.1002/gcc.20909. Epub 2011 Aug 24.

PMID:
21910158
13.
14.

Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.

Nishio J, Iwasaki H, Ishiguro M, Ohjimi Y, Fujita C, Ikegami H, Ariyoshi A, Naito M, Kaneko Y, Kikuchi M.

Int J Oncol. 2003 Mar;22(3):535-42.

PMID:
12579306
15.

A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas.

Chibon F, Mariani O, Derré J, Malinge S, Coindre JM, Guillou L, Lagacé R, Aurias A.

Cancer Genet Cytogenet. 2002 Nov;139(1):24-9.

PMID:
12547153
16.

Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.

Kanoe H, Nakayama T, Hosaka T, Murakami H, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Ron D, Sasaki MS, Toguchida J.

Oncogene. 1999 Jan 21;18(3):721-9.

17.

The ultrastructure of liposarcomas with attention to "dedifferentiation".

Chorneyko K.

Ultrastruct Pathol. 1997 Nov-Dec;21(6):545-57.

PMID:
9355237
18.

Leptin and leptin receptor mRNA are widely expressed in tumors of adipocytic differentiation.

Oliveira AM, Nascimento AG, Lloyd RV.

Mod Pathol. 2001 Jun;14(6):549-55.

19.

Dedifferentiated liposarcoma of thigh with chondrosarcomatous dedifferentiated component.

Yoon RS, Benevenia J, Beebe KS, Hameed M.

Am J Orthop (Belle Mead NJ). 2010 Nov;39(11):E114-8. Review.

PMID:
21623423
20.

Comparative genomic hybridization study of paraffin-embedded dedifferentiated liposarcoma fixed with Holland Bouin's fluid.

Hostein I, Coindre JM, Derré J, Mariani O, Chibon F, Aurias A.

Diagn Mol Pathol. 2003 Sep;12(3):166-73.

PMID:
12960699

Supplemental Content

Support Center